We are live on
!
Find out more
Balyasny Asset Management Portfolio holdings
AUM
$77.1B
1-Year Est. Return
42.89%
This Fund
S&P 500
This Quarter
Est. Return
+7.96%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$78.8B
AUM Growth
-$135M
(-0.17%)
Cap. Flow
-$4.13B
Cap. Flow
% of AUM
-5.25%
Top 10 Holdings %
Top 10 Hldgs %
14.64%
Holding
3,669
New
809
Increased
1,002
Reduced
1,102
Closed
643
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$807M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$497M |
| 3 |
RNAM
Avidity Biosciences
RNAM
|
+$390M |
| 4 |
Kenvue
KVUE
|
+$379M |
| 5 |
Broadcom
AVGO
|
+$324M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$409M |
| 2 |
Visa
V
|
+$354M |
| 3 |
Advanced Micro Devices
AMD
|
+$328M |
| 4 |
Meta Platforms (Facebook)
META
|
+$317M |
| 5 |
Lockheed Martin
LMT
|
+$316M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.61% |
| 2 | Consumer Discretionary | 9.64% |
| 3 | Healthcare | 8.17% |
| 4 | Industrials | 8.1% |
| 5 | Financials | 8.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
PUT
Goldman Sachs
GS
$301B
| $53.2M | 0.07% |
60,500
-1,100
| -2% | -$898K |
|
327
CALL
S&P Global
SPGI
$121B
| $53.1M | 0.07% |
101,700
-205,300
| -67% | -$102M |
|
328
Coca-Cola
KO
$374B
| $53.1M | 0.07% |
758,860
+116,027
| +18% | +$8.09M |
|
329
CALL
Rivian
RIVN
$23.7B
| $53M | 0.07% |
2,687,200
+203,600
| +8% | +$3.23M |
|
330
Regeneron Pharmaceuticals
REGN
$83.2B
| $52.9M | 0.07% |
68,585
+49,733
| +264% | +$33.8M |
|
331
Booz Allen Hamilton
BAH
$9.37B
| $52.8M | 0.07% |
+625,948
| New | +$56M |
|
332
COPT Defense Properties
CDP
$4.14B
| $52.7M | 0.07% |
1,896,161
+647,449
| +52% | +$18.7M |
|
|
EA
333
PUT
DELISTED
Electronic Arts
EA
| $52.7M | 0.07% |
257,800
-406,400
| -61% | -$82M |
|
334
PUT
State Street Technology Select Sector SPDR ETF
XLK
$122B
| $52.5M | 0.07% |
364,600
-161,400
| -31% | -$23.3M |
|
335
PUT
General Motors
GM
$77.2B
| $52.3M | 0.07% |
643,700
+249,400
| +63% | +$17.6M |
|
336
Cloudflare
NET
$111B
| $51.8M | 0.07% |
262,698
-7,432
| -3% | -$1.57M |
|
337
Guardant Health
GH
$22.4B
| $51.6M | 0.07% |
505,608
-27,769
| -5% | -$2.48M |
|
338
State Street Financial Select Sector SPDR ETF
XLF
$59B
| $51.6M | 0.07% |
941,523
+704,204
| +297% | +$37.5M |
|
339
Vertex Pharmaceuticals
VRTX
$133B
| $51.5M | 0.07% |
+113,488
| New | +$48.9M |
|
340
CALL
Iris Energy
IREN
$13.8B
| $51.4M | 0.07% |
1,361,400
-54,000
| -4% | -$2.79M |
|
341
Cogent Biosciences
COGT
$7.1B
| $51.2M | 0.06% |
1,440,318
-1,230,168
| -46% | -$34.6M |
|
342
Walt Disney
DIS
$178B
| $51M | 0.06% |
448,277
-42,907
| -9% | -$4.73M |
|
343
American Express
AXP
$229B
| $50.8M | 0.06% |
137,270
+91,993
| +203% | +$32.9M |
|
|
NBIS
344
CALL
Nebius Group N.V.
NBIS
$46.7B
| $50.8M | 0.06% |
606,500
+50,000
| +9% | +$5.18M |
|
345
FTAI Aviation
FTAI
$22.1B
| $50.5M | 0.06% |
256,762
-11,481
| -4% | -$1.96M |
|
346
Penumbra
PEN
$12.8B
| $50.3M | 0.06% |
161,911
-9,712
| -6% | -$2.68M |
|
347
PUT
Lam Research
LRCX
$383B
| $50.3M | 0.06% |
293,600
-151,300
| -34% | -$23.5M |
|
348
RH
RH
$3.47B
| $50M | 0.06% |
+278,930
| New | +$47.7M |
|
|
P
349
Everpure Inc
P
$32.6B
| $49.6M | 0.06% |
739,567
+695,069
| +1,562% | +$58.1M |
|
350
Acuity Brands
AYI
$10.6B
| $49.3M | 0.06% |
136,963
+64,746
| +90% | +$23.4M |
|
Similar funds
CBU
BC
Balyasny Asset Management's Q4 2025 Portfolio in Review
As of Q4 2025, Balyasny Asset Management held 3,669 positions worth $78.8B, down 0.17% from $78.9B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Balyasny Asset Management withdrew a net $4.13B in Q4 2025, closing 643 positions and reducing 1,102 holdings. Its most notable exit was Mr. Cooper, an estimated $277M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Balyasny Asset Management opened a new position in Avidity Biosciences worth $436M.
- Balyasny Asset Management's largest Q4 2025 buy was Avidity Biosciences: 6,040,590 shares worth $436M.
- Balyasny Asset Management added most to Amazon in Q4 2025, an estimated $807M increase.
- Balyasny Asset Management's biggest Q4 2025 reduction was Apple, cutting an estimated $409M.
- Balyasny Asset Management fully exited Mr. Cooper in Q4 2025, selling an estimated $277M.
- Balyasny Asset Management's ten largest holdings make up 15% of its $78.8B portfolio in Q4 2025.
- Balyasny Asset Management opened 809 new positions and closed 643 in Q4 2025.
- Balyasny Asset Management's portfolio value fell 0.17% quarter-over-quarter to $78.8B.
Based on Balyasny Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.